SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-22-047343
Filing Date
2022-04-19
Accepted
2022-04-19 16:15:48
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2212715d2_defa14a.htm DEFA14A 11562
2 GRAPHIC tm2212715d2_defa14aimg01.jpg GRAPHIC 1406439
3 GRAPHIC tm2212715d2_defa14aimg02.jpg GRAPHIC 1837813
  Complete submission text file 0001104659-22-047343.txt   4479238
Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address 6 TIDE STREET BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Filer) CIK: 0001689375 (see all company filings)

IRS No.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40969 | Film No.: 22835119
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences